Irritation and Sensitization Potential of Repeat Applications of Rotigotine Patch

Clinical trial NCT02727205 · COMPLETED

Trial details

NCT number: NCT02727205
Sponsor: Inflamax Research Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch

Start date: 2013-08-01
Primary completion: 2013-10-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.